Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Gogo Inc.GOGO · Entity 5812 | Director | March 31, 2025 | April 02, 2025 |
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director | August 14, 2026 | August 18, 2026 |
| Robinhood Markets, Inc.HOOD · Entity 584 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Gogo Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 183,524 |
Reported balance
After 2025-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-31 · Grant · Acquired 6,960 · Balance 183,524 F1: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2: These deferred share units were granted on March 31, 2025, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred share unit represents the contingent right to receive one share of the Company's common stock.
F2: These deferred share units were granted on March 31, 2025, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors.
Hims & Hers Health, Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 34,863 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 545 · Balance 34,863 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-14 · Exercise / conversion · Disposed 545 · Balance 0 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by The Payne Family Trust dtd 09/17/2020 | 110,000 |
Reported balance
Holding disclosure · report date 2026-08-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 110,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
Robinhood Markets, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 221 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 211 · Balance 221 F1: On September 30, 2026, the Reporting Person was automatically granted 211 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the September 30, 2026 closing price of $112.50 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 26,500 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 26,500 |
Filing footnotes · ownership attribution and instrument terms
F1: On September 30, 2026, the Reporting Person was automatically granted 211 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the September 30, 2026 closing price of $112.50 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DoorDash, Inc.
Report date February 28, 2023 · Filed March 03, 2023
Section 16 reporting ended · disclosed 2023-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 322,951 |
Reported balance
After 2023-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-28 · Sale · Disposed 1,807 · Balance 322,951 F1: Shares sold to cover tax obligations in connection with the vesting of restricted stock units ("RSUs"). F2: Certain of these securities are represented by RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to cover tax obligations in connection with the vesting of restricted stock units ("RSUs").
F2: Certain of these securities are represented by RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:09 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001612163-26-000011 · wk-form4_1790975395.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221 F1 · price: On September 30, 2026, the Reporting Person was automatically granted 211 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the September 30, 2026 closing price of $112.50 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 545 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000205 · wk-form4_1787087010.xml · derivative · entry 3 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000205 · wk-form4_1787087010.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 545 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000191 · wk-form4_1786738562.xml · derivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 545 Underlying: Class A Common Stock · 545 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. F3 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 8,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000191 · wk-form4_1786738562.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,223 Underlying: Class A Common Stock · 8,223 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award. F2 · derivative.expiration_date: Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:16 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001612163-26-000009 · wk-form4_1783026981.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246 F1 · price: On June 30, 2026, the Reporting Person was automatically granted 236 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the June 30, 2026 closing price of $100.28 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 647 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · derivative · entry 7 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 10,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · derivative · entry 6 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,040 Underlying: Class A Common Stock · 10,040 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · nonDerivative · entry 3 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,040 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · nonDerivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · derivative · entry 5 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,656 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 3,656 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000110 · wk-form4_1781557982.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:58 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantRestricted Stock Units · Derivative | 3,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001612163-26-000006 · wk-form4_1780520290.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,289 Underlying: Class A Common Stock · 3,289 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement. F2 · kind: This RSU award represents the Reporting Person's annual grant pursuant to the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood") and was granted automatically on the date of Robinhood's annual meeting of stockholders. F3 · derivative.exercise_date: On June 2, 2026, the Reporting Person was granted 3,289 RSUs under Robinhood's 2021 Omnibus Incentive Plan. One-fourth (1/4) of these RSUs will vest on October 1, 2026, with the remainder vesting in three (3) equal quarterly installments thereafter (except the final installment will vest no later than the day before Robinhood's 2027 annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) his death or disability, or (3) a change in control of Robinhood. F3 · derivative.expiration_date: On June 2, 2026, the Reporting Person was granted 3,289 RSUs under Robinhood's 2021 Omnibus Incentive Plan. One-fourth (1/4) of these RSUs will vest on October 1, 2026, with the remainder vesting in three (3) equal quarterly installments thereafter (except the final installment will vest no later than the day before Robinhood's 2027 annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) his death or disability, or (3) a change in control of Robinhood. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 647 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000083 · wk-form4_1779480968.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 647 Underlying: Class A Common Stock · 647 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:55 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001612163-26-000004 · wk-form4_1775163322.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293 F1 · price: On March 31, 2026, the Reporting Person was automatically granted 283 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the March 31, 2026 closing price of $69.30 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:02 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001612163-26-000002 · wk-form4_1767650553.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183 F1 · price: On December 31, 2025, the Reporting Person was automatically granted 173 shares of Class A Common Stock under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the December 31, 2025 closing price of $113.10 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:14 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 116 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001783879-25-000288 · wk-form4_1759439688.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126 F1 · price: On September 30, 2025, the Reporting Person was automatically granted 116 shares of Class A under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the September 30, 2025 closing price of $143.18 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 3,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000270 · wk-form4_1754684399.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,656 Underlying: Class A Common Stock · 3,656 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 21:12 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001783879-25-000229 · wk-form4_1751490714.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183 F1 · price: On June 30, 2025, the Reporting Person was automatically granted 173 shares of Class A under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the June 30, 2025 closing price of $93.63 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 21:02 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantRestricted Stock Units · Derivative | 3,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001783879-25-000206 · wk-form4_1750971740.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,202 Underlying: Class A Common Stock · 3,202 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement. F2 · kind: This RSU award represents the Reporting Person's annual grant pursuant to the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood") and was granted automatically on the date of Robinhood's annual meeting of stockholders. F3 · derivative.exercise_date: On June 25, 2025, the Reporting Person was granted 3,202 RSUs under Robinhood's 2021 Omnibus Incentive Plan. One-fourth (1/4) of these RSUs will vest on October 1, 2025, with the remainder vesting in three (3) equal quarterly installments thereafter (except the final installment will vest no later than the day before Robinhood's 2026 annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. F3 · derivative.expiration_date: On June 25, 2025, the Reporting Person was granted 3,202 RSUs under Robinhood's 2021 Omnibus Incentive Plan. One-fourth (1/4) of these RSUs will vest on October 1, 2025, with the remainder vesting in three (3) equal quarterly installments thereafter (except the final installment will vest no later than the day before Robinhood's 2026 annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 00:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 10,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000207 · wk-form4_1750120745.xml · derivative · entry 5 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,080 Underlying: Class A Common Stock · 10,040 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on June 15, 2027. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on June 15, 2027. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 00:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,040 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-25-000207 · wk-form4_1750120745.xml · nonDerivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 21:27 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | PurchaseClass A Common Stock | 26,500 | $74.19 | $1,965,995.25 |
DisclosureSEC source: 0001783879-25-000189 · wk-form4_1750195641.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 26,500 F1 · price: This transaction was executed in multiple trades during the day at prices ranging from $73.97 to $74.35. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the trades were made. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000207 · wk-form4_1750120745.xml · derivative · entry 4 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:39 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-25-000207 · wk-form4_1750120745.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:43 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001783879-25-000119 · wk-form4_1743633793.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366 F1 · price: On March 31, 2025, the Reporting Person was automatically granted 356 shares of Class A under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and Robinhood's 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the March 31, 2025 closing price of $41.62 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) January 1, 2035, (2) their death or disability, or (3) a change in control of Robinhood. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:10 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 6,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028025 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,524 Underlying: Common Stock · 6,960 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on March 31, 2025, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on March 31, 2025, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:07 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 7,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-000750 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,564 Underlying: Common Stock · 7,416 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on December 31, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on December 31, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 20:10 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantClass A Common Stock | 68 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001783879-25-000013 · wk-form4_1735935027.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78 F1 · price: On December 31, 2024, the Reporting Person was automatically granted 68 shares of Class A under the Non-Employee Director Compensation Program of Robinhood Markets, Inc. ("Robinhood"), which permits directors to elect to receive payment of quarterly director fees in the form of stock, and the Robinhood 2021 Omnibus Incentive Plan. This grant was made in lieu of cash fees, based on the December 31, 2024 closing price of $37.26 per share of Class A Common Stock, and these shares were fully vested upon grant. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1)1/1/2035, (2) his death or disability, or (3) a change in control of Robinhood. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:13 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantRestricted Stock Units · Derivative | 2,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001783879-24-000342 · wk-form4_1734563615.xml · derivative · entry 3 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,739 Underlying: Class A Common Stock · 2,739 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement. F4 · deemedExecutionDate: This RSU award represents the Reporting Person's pro-rated annual grant pursuant to the Non-Employee Director Compensation Program and was granted automatically on the date the Reporting Person joined the Board. F5 · derivative.exercise_date: On December 16, 2024, the Reporting Person was granted 2,739 RSUs under the 2021 Plan. Of that amount, 222 RSUs are scheduled to vest on January 1, 2025, 1,251 RSUs are scheduled to vest on April 1, 2025 and 1,266 RSUs are scheduled to vest on July 1, 2025 (or, if earlier, the day before Robinhood's next annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) 1/1/2035, (2) his death or disability, or (3) a change in control of Robinhood. F5 · derivative.expiration_date: On December 16, 2024, the Reporting Person was granted 2,739 RSUs under the 2021 Plan. Of that amount, 222 RSUs are scheduled to vest on January 1, 2025, 1,251 RSUs are scheduled to vest on April 1, 2025 and 1,266 RSUs are scheduled to vest on July 1, 2025 (or, if earlier, the day before Robinhood's next annual meeting of stockholders), in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) 1/1/2035, (2) his death or disability, or (3) a change in control of Robinhood. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:13 UTC | Robinhood Markets, Inc. HOOD · Entity 584 | GrantRestricted Stock Units · Derivative | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001783879-24-000342 · wk-form4_1734563615.xml · derivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,208 Underlying: Class A Common Stock · 5,208 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement. F2 · deemedExecutionDate: This RSU award represent the Reporting Person's initial equity grant pursuant to the Non-Employee Director Compensation Program and was granted automatically on the date the Reporting Person joined the Board of Directors (the "Board") of Robinhood Markets, Inc. ("Robinhood"). F3 · derivative.exercise_date: On December 16, 2024, the Reporting Person was granted 5,208 RSUs under Robinhood's 2021 Omnibus Incentive Plan (the "2021 Plan"). One-twelfth (1/12) of these RSUs are scheduled to vest on April 1, 2025, with the remainder scheduled to vest in eleven (11) equal quarterly installments thereafter, in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) 1/1/2035, (2) his death or disability, or (3) a change in control of Robinhood. F3 · derivative.expiration_date: On December 16, 2024, the Reporting Person was granted 5,208 RSUs under Robinhood's 2021 Omnibus Incentive Plan (the "2021 Plan"). One-twelfth (1/12) of these RSUs are scheduled to vest on April 1, 2025, with the remainder scheduled to vest in eleven (11) equal quarterly installments thereafter, in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances. Pursuant to a deferral election, vested shares will be delivered to the Reporting Person upon the earliest to occur of (1) 1/1/2035, (2) his death or disability, or (3) a change in control of Robinhood. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:01 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 8,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-084638 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,148 Underlying: Common Stock · 8,356 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on September 30, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on September 30, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| August 07, 2024 Filed Aug 8, 2024 20:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 9,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000266 · wk-form4_1723148653.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,935 Underlying: Class A Common Stock · 9,935 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:01 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 6,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-058580 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,792 Underlying: Common Stock · 6,237 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on June 30, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on June 30, 2024, and will vest in full on the one-year anniversary of the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 110,000 | $17.74 | $1,951,763.00 |
DisclosureSEC source: 0001773751-24-000151 · wk-form4_1716408966.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by The Payne Family Trust dtd 09/17/2020 Disclosed balance after: 110,000 F1 · price: Price reported constitutes the average weighted price of shares purchased. Shares were purchased at varying prices in the range of $17.64 - $17.855. The Reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 08, 2024 Filed May 9, 2024 20:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 30,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000135 · wk-form4_1715285187.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,120 Underlying: Class A Common Stock · 30,120 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on June 15, 2027. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on June 15, 2027. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 22:54 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 6,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-029488 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,555 Underlying: Common Stock · 6,833 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on March 31, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on March 31, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| December 29, 2023 Filed Jan 4, 2024 01:37 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 5,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-000938 · ownership.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,722 Underlying: Common Stock · 5,923 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on December 29, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on December 29, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:15 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 5,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051444 · doc4.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,799 Underlying: Common Stock · 5,029 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on September 30, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on September 30, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:19 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 3,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041034 · doc4.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,770 Underlying: Common Stock · 3,527 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on June 30, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on June 30, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:29 UTC | Gogo Inc. GOGO · Entity 5812 | GrantDeferred Share Units · Derivative | 4,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-022871 · doc4.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,243 Underlying: Common Stock · 4,137 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share unit represents the contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: These deferred share units were granted on March 31, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. F2 · derivative.expiration_date: These deferred share units were granted on March 31, 2023, and are fully vested on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:51 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 1,807 | $58.39 | $105,507.12 |
DisclosureSEC source: 0001209191-23-014964 · doc4.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,951 F1 · kind: Shares sold to cover tax obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · balance_after: Certain of these securities are represented by RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:19 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 5,096 | $59.24 | $301,876.85 |
DisclosureSEC source: 0001209191-23-012165 · doc4.xml · nonDerivative · entry 2 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,758 F1 · kind: Shares sold to cover tax obligations in connection with the vesting of restricted stock units ("RSUs"). F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $58.96 to $59.438 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Certain of these securities are represented by RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:19 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 24,089 | $58.21 | $1,402,172.51 |
DisclosureSEC source: 0001209191-23-012165 · doc4.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,854 F1 · kind: Shares sold to cover tax obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $57.77 to $58.765 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Certain of these securities are represented by RSUs. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:27 UTC | DoorDash, Inc. DASH · Entity 1541 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 47,093 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-23-008721 · doc4.xml · derivative · entry 4 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,470,554 Underlying: Class A Common Stock · 47,093 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Relates to the exercise of an option to purchase shares of the Issuer's Class A common stock pursuant to a Rule 10b5-1 trading plan in advance of such option's expiration on January 14, 2026. F6 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:27 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 21,589 | $63.70 | $1,375,240.89 |
DisclosureSEC source: 0001209191-23-008721 · doc4.xml · nonDerivative · entry 3 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,943 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This sale price represents the weighted average sale price of the shares sold ranging from $63.31 to $64.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · balance_after: Certain of these securities are represented by restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:27 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 25,504 | $62.89 | $1,603,946.56 |
DisclosureSEC source: 0001209191-23-008721 · doc4.xml · nonDerivative · entry 2 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,532 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $62.30 to $63.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · balance_after: Certain of these securities are represented by restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:27 UTC | DoorDash, Inc. DASH · Entity 1541 | Exercise / conversionClass A Common Stock | 47,093 | $1.50 | $70,639.50 |
DisclosureSEC source: 0001209191-23-008721 · doc4.xml · nonDerivative · entry 1 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Relates to the exercise of an option to purchase shares of the Issuer's Class A common stock pursuant to a Rule 10b5-1 trading plan in advance of such option's expiration on January 14, 2026. F2 · balance_after: Certain of these securities are represented by restricted stock units. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 21:02 UTC | DoorDash, Inc. DASH · Entity 1541 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 47,093 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-23-002969 · doc4.xml · derivative · entry 6 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517,647 Underlying: Class A Common Stock · 47,093 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Relates to the exercise of an option to purchase shares of the Issuer's Class A common stock pursuant to a Rule 10b5-1 trading plan in advance of such option's expiration on January 14, 2026. F8 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 21:02 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 756 | $49.33 | $37,294.24 |
DisclosureSEC source: 0001209191-23-002969 · doc4.xml · nonDerivative · entry 5 Payne Christopher D · CIK 0001612163 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,943 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: This sale price represents the weighted average sale price of the shares sold ranging from $49.28 to $49.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · balance_after: Certain of these securities are represented by restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.